Login / Signup

The effectiveness of Botulinum Toxin A for treatment of upper limb impairments and dysfunctions in breast cancer survivors: A randomised controlled trial.

An De GroefNele DevoogdtMarijke Van KampenLaura De HertoghMargot VergoteInge GeraertsLore DamsElien Van der GuchtPhilippe Debeer
Published in: European journal of cancer care (2019)
A single Botulinum Toxin A (BTX-A) infiltration in the pectoralis major muscle, in addition to a PT programme cannot be recommended to treat upper limb impairments and dysfunctions after breast cancer treatment.
Keyphrases
  • upper limb
  • botulinum toxin
  • randomized controlled trial
  • systematic review
  • skeletal muscle
  • combination therapy
  • smoking cessation